Endometrial Hyperplasia Clinical Trials

A listing of Endometrial Hyperplasia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

To compare the efficacy of Medroxyprogesterone Acetate with dydrogesterone in patients having endometrial hyperplasia (EH) without atypia.

  • 0 views
  • 20 Jun, 2022
  • 1 location
Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia

This study will prospectively enroll a total of 1000 patients (200 per year) simple hyperplasia/complex hyperplasia (SH/CH) without atypia. All subjects will receive education for exercise and weight control and be randomized 1:1 to with or without metformin intervention. At the end of this 3-year project, an interim analysis will …

  • 0 views
  • 11 Apr, 2022
  • 1 location
Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

To see if megestrol acetate plus rosuvastatin will be superior to reversing the endometrial lesion to a normal endometrium than megestrol acetate alone in patients with atypical endometrial

adjunctive treatment
atypical endometrial hyperplasia
megestrol acetate
blood lipid
lipoprotein cholesterol
  • 0 views
  • 01 Sep, 2021
  • 1 location
LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia

produce complete regression for cases with atypical endometrial hyperplasia.

levonorgestrel
progestin
hysterectomy
atypical endometrial hyperplasia
megestrol acetate
  • 24 views
  • 01 May, 2022
  • 1 location
Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

The purpose of this research study is to compare the uterus tissue of women who receive an intrauterine system to treat their endometrial hyperplasia with the uterine tissue of women who receive

levonorgestrel
atypical endometrial hyperplasia
dilation and curettage
megestrol acetate
progesterone
  • 0 views
  • 29 May, 2022
  • 1 location
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

To investigate the efficacy of weight management plus levonorgestrel intrauterine system (LNG-IUS) or megestrol acetate (MA) in obese patients with endometrial atypical hyperplasia (EAH) asking for conservative therapy.

  • 0 views
  • 28 Jun, 2022
  • 1 location
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

atypical endometrial hyperplasia and early endometrial carcinoma, including pathology response and pregnancy outcome. Second end points: To analyze the appearances of side-effects.

metastasis
uterine disease
endometrial hyperplasia
levonorgestrel
atypical endometrial hyperplasia
  • 49 views
  • 28 Feb, 2022
  • 1 location
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

This phase II trial studies how well megestrol acetate with or without pterostilbene works in treating patients with endometrial cancer undergoing hysterectomy. Drugs used in chemotherapy, such as megestrol acetate, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from …

total bilirubin
serum pregnancy test
atypical hyperplasia
atypical endometrial hyperplasia
megestrol acetate
  • 2 views
  • 01 Jul, 2022
  • 1 location
Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

To study if polyethylene glycol loxenatide plus levonorgestrel-releasing intrauterine system (LNG-IUS) will improve response rates in patients with endometrial atypical hyperplasia.

body mass index
levonorgestrel
atypical hyperplasia
  • 0 views
  • 26 Mar, 2022
  • 1 location
Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia

This study protocol evaluates the use of hysteroscopic endomyometrial resection in women diagnosed with atypical endometrial hyperplasia or grade I endometrial cancer who have not responded to

progestin
uterine disease
hyperplasia
hormone therapy
atypical endometrial hyperplasia
  • 0 views
  • 30 Oct, 2021
  • 1 location